Results 21 to 30 of about 1,673 (95)
EFFICACY OF VACCINE PREVENTION OF HPV-ASSOCIATED DISEASES AND CERVICAL CANCER IN THE MOSCOW REGION
Alʹmanah Kliničeskoj Mediciny, 2016 Data on high prevalence of papilloma virus infection and associated disorders in adults as well as in adolescents are becoming more and more frequently published in the world and domestic literature.
V. I. Krasnopol'skiy +5 more
doaj +1 more source
Ongoing challenges and future directions of human papillomavirus vaccination
Безопасность и риск фармакотерапии, 2020 Cervical cancer caused by human papillomavirus (HPV) types 16 and 18 is one of the most common cancer types in women. Other high-risk HPV types may cause vaginal cancer, vulval cancer, penile cancer, anal cancer, head and neck cancer. Low-risk HPV types,
O. S. Alyautdina, V. Yu. Prilutskaya
doaj +1 more source
Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong. [PDF]
PLoS ONE, 2013 This study explored the knowledge, attitude, practice and barriers to prescribe human papillomavirus (HPV) vaccines among private primary care physicians in Hong Kong.
Martin C S Wong +4 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2018 Human papillomavirus (HPV) infection is a frequent cause of malignant and non-malignant disease, in particular among persons with HIV. HPV serotype-specific anti L1 antibodies protect against HPV infection but little is known about prophylactic HPV ...
Maria Zurek Munk-Madsen +7 more
doaj +1 more source
Heliyon, 2023 Toll-like receptor (TLR) agonists are recognized as potential immune-enhancing adjuvants and are included in several licensed vaccines. Monophosphoryl lipid A (MPL®, GlaxoSmithKline) is one such TLR4 agonist that has been approved for use in human ...
Gang Hu +7 more
doaj +1 more source
Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
British Journal of Pharmacology, EarlyView.This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu +6 more
wiley +1 more source
International Journal of Infectious DiseasesCervical cancer remains a leading cause of death among women in sub-Saharan Africa, accounting for nearly a quarter of global deaths from this disease. Its high incidence is due to the high prevalence of HIV, the persistence of human papillomavirus (HPV)
Christian Tague +10 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2019 High-risk human papillomavirus (HPV) types are responsible for nearly all cases of cervical cancers. Cervarix® and Gardasil® 9 are the current prophylactic vaccines available that protect against the majority of HPVs associated with cancer.
Nitesh K. Kunda +6 more
doaj +1 more source
The International Journal of Health Planning and Management, Volume 41, Issue 4, Page 572-579, July 2026.ABSTRACT Introduction This project explores influenza and human papillomavirus (HPV) vaccine utilisation among a multi‐ethnic group of youth (aged 11–23 years) in Edmonton, Alberta, Canada. Method Using a cross‐sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire.
Sarah Deck +5 more
wiley +1 more source
MODERN ASPECTS OF HUMAN PAPILLOMAVIRUS VACCINATION
Безопасность и риск фармакотерапии, 2018 Human papillomavirus refers to DNA-containing viruses and infects the skin and mucosal epithelium. One common way is to change the expression of cellular genes by integrating the viral genome into cellular DNA.
O. S. Alyautdina, M. A. Darmostukova
doaj +1 more source